Table 2.
Impact of the COVID-19 pandemic on clinical symptoms, hospital visits and medication usage
| Migraine patients (n = 606) | |
|---|---|
| Stress, n (%) | |
| Decreased | 30 (5.0) |
| Unchanged | 232 (38.3) |
| Increased | 344 (56.8) |
| Physical activity, n (%) | |
| Decreased | 305 (50.3) |
| Unchanged | 268 (44.2) |
| Increased | 33 (5.4) |
| Impact of COVID-19 epidemic on daily life, n (%) | 273 (45.0) |
| Interest in COVID-19, n (%) | |
| None | 1 (0.2) |
| Very little | 3 (0.5) |
| Little | 37 (6.1) |
| Moderate | 139 (22.9) |
| Strong | 426 (70.3) |
| Concerns about COVID-19, n (%) | |
| None | 4 (0.7) |
| Very minor | 10 (1.7) |
| Minor | 83 (13.7) |
| Moderate | 175 (28.9) |
| Great | 334 (55.1) |
| PGIC scale (1–7) | |
| Mood | 4.5 ± 0.9 |
| Sleep | 4.4 ± 0.99 |
| aAcute headache treatment, n (%) | |
| Decreased | 53 (8.7) |
| Unchanged | 367 (60.6) |
| Increased | 186 (30.7) |
| Addition or changes in headache-prevention medications, n (%) | 94 (15.5) |
| Occupation, n (%) | |
| Frontline worker | 193 (31.8) |
| Working from home | 224 (37.0) |
| Other occupations | 189 (31.2) |
| Problems with hospital access, n (%) | 95 (15.7) |
| Medication shortage, (n%) | 43 (7.1) |
| Received online medical care | |
| Yes, n (%) | 95 (15.7) |
| - If yes, what are the advantages and disadvantages? | |
| Advantages | |
| Infection risk reduction | 91 (95.8) |
| Able to continue working | 22 (23.2) |
| Remain with children | 10 (10.5) |
| Others | 13 (13.7) |
| Disadvantages | |
| Short examination times | 35 (36.8) |
| Time schedule conflicts | 4 (4.2) |
| Unfamiliar with the method | 4 (4.2) |
| None | 48 (50.5) |
| Others | 5 (5.3) |
| No, n (%) | 511 (95) |
| - If no, would you like to receive telephone/online care in the future? | 264 (51.7) |
PGIC patient global impression of change
adose or type, after the state of emergency declaration